Viome is a longevity and preventative healthcare company that offers oral microbiome and gut microbiome testing services, founded by Deepak Savadatti and Naveen Jain.
Viome has been criticized for lackinghaving insufficient scientific evidence for its products and promoting placebos over scientifically supported healthrecommended interventions. Founder Naveen Jain has been reported to have made some statements that lack a sound basis. Jain is reported to have made the claim that every chronic disease is caused by gut issues. Jain is reported to have said that the health-care system and the pharmaceutical industry are financially invested in keeping the public as patients, not really wanting people to be well.
Viome has been criticized for lacking evidence and promoting placebos over scientifically supported health interventions. Founder Naveen Jain has been reported to have made some statements that lack a sound basis. Jain is reported to have made the claim that every chronic disease is caused by gut issues. Jain is reported to have said that the health-care system and the pharmaceutical industry are financially invested in keeping the public as patients, not really wanting people to be well.
November 2, 2023
August 18, 2023
July 27, 2023
Viome is a longevity and preventative healthcare company that offers oral microbiome and gut microbiome testing services, founded by Deepak Savadatti and Naveen Jain.
Viome is a health company that has the goal of discovering predictive biomarkers in order to get rid of all diseases. The company was founded by Deepak Savadatti and Naveen Jain in 2016, in Los Alamos, New Mexico, USA.
Viome is a longevity and preventative healthcare company that combines RNA sequencing and AI technology with the goal of discovering predictive biomarkers to prevent diseases. Viome markets home-based tests which provide personalized nutritional guidance and also sells microbiome health products. The company was founded by Deepak Savadatti and Naveen Jain in 2016, in Los Alamos, New Mexico, USA.
The company's artificial learning engines analyze and aggregate all recieved biological data the receive, allowing the machine learning to find trends, patterns, and influences, and ultimately breakthroughs. The way the data is collected is through a microbiome analysis kit customers use to get a snapshot of the microbes living inside their gut. Then Viome offers basic recommendations on how dietary changes could affect their health. Assessing microbiome health and maintaining it can reduce or slow progressions of diseases like depression, osteoarthritis, functional bowel diseases, and multiple sclerosis. Viome aims to make use userof data collected from users to spot trends in gut biome health and support scientific research in the area.
Viome has raised over $25 million and pursues about 15 clinical research trials and is focused on eventually developing treatments. Their tests have origins from technology from a company, BlueDot, which is from Los Alamos National Laboratory. They test a variant on sequencing ribonucleic acid, or the messenger mechanism that provides cells with instructions on what to produce.
Viome had raised over $25 million by 2019. At that time Viome was pursuing about 15 clinical research trials and aimed to develop thier own treatments. Their tests have origins from technology from a company, BlueDot, which is from Los Alamos National Laboratory and is a type of RNA sequencing. RNA sequencing analyses the messenger molecules that provide cells with instructions on which proteins to produce. Researchers at Viome aim to use RNA sequencing to show signaling and metabolic pathways active in bacteria in the body, which can have positive and negative impacts on health .Viome sequences the users RNA and can identify and quantify all of the living microorganisms in the gut (bacteria, viruses, bacteriophages, archaea, fungi, yeast, parasites, and more) at the species and strain level.
Viome sequences the users RNA and can identify and quantify all of the living microorganisms in the gut (bacteria, viruses, bacteriophages, archaea, fungi, yeast, parasites, and more) at the species and strain level.
Viome launched the Gut Intelligence Test in 2023 into 200 CVS pharmacy locations in the US, and was the first gut test available in the national retail chain. Also in 2023, Viome announced its Oral Health Solutions kit which includes Oral Health Intelligence Test, VRx My Biotics Oral Lozenges and Precision Supplements. The Oral Health Solutions product aims to provide RNA-driven oral health scores and personalized plans to improve the balance of oral bacteria. The lozenges contain a personalized blend of beneficial bacteria and other ingredients that aim to benefit the oral microbiome.